M&A Deal Summary

Genesis Biotechnology Group Acquires PharmOptima

On March 1, 2017, Genesis Biotechnology Group acquired life science company PharmOptima

Acquisition Highlights
  • This is Genesis Biotechnology Group’s 1st transaction in the Life Science sector.
  • This is Genesis Biotechnology Group’s 1st transaction in the United States.
  • This is Genesis Biotechnology Group’s 1st transaction in Michigan.

M&A Deal Summary
Date 2017-03-01
Target PharmOptima
Sector Life Science
Buyer(s) Genesis Biotechnology Group
Deal Type Add-on Acquisition

Target

PharmOptima

Portage, Michigan, United States
PharmOptima LLC is a drug discovery and development in various therapeutic areas and has filled a niche in ocular drug development.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Genesis Biotechnology Group

Hamilton, New Jersey, United States
Category Company
Sector Life Science
DESCRIPTION

Genesis Biotechnology Group is a consortium of vertically integrated corporate research entities, which facilitates the overall market implementation and delivery of biomedical science products and services related to diagnostics and drug discovery.

DEAL STATS #
Overall 1 of 5
Sector (Life Science) 1 of 4
Type (Add-on Acquisition) 1 of 5
State (Michigan) 1 of 1
Country (United States) 1 of 5
Year (2017) 1 of 2
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-08-03 4path

Burr Ridge, Illinois, United States

4path Ltd. is a provider of highly personalized diagnostic services with expertise in Podiatry, Gastroenterology, Urology, Dermatology, Breast, Gynecology, Orthopedics and other specialties. 4path is based in Burr Ridge, Illinois.

Buy -
Mergr

Product

Company

Legal